1 November 2024 in Journal of Chemical Information and Modeling
24 July 2023 in Briefings in Bioinformatics
Numerous biological studies have shown that considering disease-associated micro RNAs (miRNAs) as potential biomarkers or therapeutic targets offers new avenues for the diagnosis of complex diseases. Computational methods have gradually been introduced to reveal disease-related miRNAs. Considering that previous models have not fused sufficiently diverse similarities, that their inappropriate fusion methods may lead to poor quality of the comprehensive similarity network and that their results are often limited by insufficiently known associations, we propose a computational model called Generative Adversarial Matrix Completion Network based on Multi-source Data Fusion (GAMCNMDF) for miRNA–disease association prediction. We create a diverse network connecting miRNAs and diseases, which is then represented using a matrix. The main task of GAMCNMDF is to complete the matrix and obtain the predicted results. The main innovations of GAMCNMDF are reflected in two aspects: GAMCNMDF integrates diverse data sources and employs a nonlinear fusion approach to update the similarity networks of miRNAs and diseases. Also, some additional information is provided to GAMCNMDF in the form of a ‘hint’ so that GAMCNMDF can work successfully even when complete data are not available. Compared with other methods, the outcomes of 10-fold cross-validation on two distinct databases validate the superior performance of GAMCNMDF with statistically significant results. It is worth mentioning that we apply GAMCNMDF in the identification of underlying small molecule-related miRNAs, yielding outstanding performance results in this specific domain. In addition, two case studies about two important neoplasms show that GAMCNMDF is a promising prediction method.
21 February 2025 in Journal of Chemical Information and Modeling
28 July 2025 in IEEE Transactions on Consumer Electronics
Within the domain of consumer health electronics, precise prediction of miRNA–drug associations plays a vital role in enhancing therapeutic approaches and accelerating the drug discovery process. Traditional approaches often suffer from high computational costs and limited capability to capture intricate patterns in complex and heterogeneous datasets. To address these challenges, we present ALRTGCL, a novel framework designed to significantly enhance miRNA–drug association prediction by combining an Adaptive Low-Rank Transformer with Graph Contrastive Learning. The core innovation of ALRTGCL is its adaptive low-rank attention mechanism, which dynamically adjusts attention scores based on data characteristics, thereby reducing model complexity and computational overhead without compromising predictive accuracy. In addition, we incorporate graph contrastive learning to capture diverse graph-based perspectives of the data. This methodology refines the representation of miRNA–drug associations by exploiting subtle differences across multiple data views, thereby enhancing the model’s ability to capture complex relationships and improve its overall performance. We evaluate ALRTGCL through extensive experiments on multiple benchmark datasets, demonstrating its superior predictive accuracy and scalability. The results position ALRTGCL as a highly effective tool for personalized medicine and health monitoring applications, with its computational efficiency making it ideal for integration into medical electronic devices that promote healthy patient behaviors.
17 June 2025 in Journal of Chemical Information and Modeling
23 January 2026 in Engineering Applications of Artificial Intelligence